Live news related to INNATE PHARMA stock (FR0010331421): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on INNATE PHARMA mainly cover analyst notes, guidance and outlook et share price moves. The stock trades at €1,59 on Euronext Paris, up 0,76% at the last update. This page lists the articles published on INNATE PHARMA stock to track the share price, company announcements and any item likely to influence market perception.
The Marseille-based biotechnology group announced its participation in a leading virtual conference organized by BTIG on July 28, 2026. Sonia Quaratin…
The biopharmaceutical laboratory announced the completion of recruitment in the dose escalation part of its Phase 1 study evaluating IPH4502, a drug-c…
Portzamparc ajuste ce vendredi son objectif de cours sur Innate Pharma.
